Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Evolus Inc (EOLS)  
$11.43 0.03 (0.26%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 57,760,000
Market Cap: 660.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $7.15 - $14.91
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Evolus is a beauty company focused on delivering products in the self-pay aesthetic market. Co.'s commercial product is Jeuveau® (prabotulinumtoxinA-xvfs), a proprietary purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Co.'s primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 174,967 224,934
Total Buy Value $0 $0 $1,296,505 $1,776,503
Total People Bought 0 0 1 4
Total Buy Transactions 0 0 1 7
Total Shares Sold 159,356 242,004 1,955,045 6,452,816
Total Sell Value $2,199,542 $3,021,938 $15,929,922 $55,083,596
Total People Sold 4 4 5 8
Total Sell Transactions 8 10 15 33
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 183
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Moatazedi David See Remarks   •       •      –    2024-03-27 4 S $13.86 $86,431 D/D (6,236) 689,614 18%     
   Moatazedi David See Remarks   •       •      –    2024-03-19 4 S $13.92 $1,344,604 D/D (96,566) 695,850 18%     
   Avelar Rui See Remarks   •       –      –    2024-03-19 4 S $13.92 $384,350 D/D (27,603) 372,288 18%     
   Beaver Sandra Chief Financial Officer   •       –      –    2024-03-19 4 S $13.92 $78,978 D/D (5,672) 154,201 18%     
   Avelar Rui See Remarks   •       –      –    2024-02-22 4 AS $13.08 $23,821 D/D (1,821) 399,891 -12%     
   Moatazedi David See Remarks   •       •      –    2024-02-22 4 AS $13.08 $100,804 D/D (7,706) 792,416 -12%     
   Beaver Sandra Chief Financial Officer   •       –      –    2024-02-22 4 AS $13.08 $23,821 D/D (1,821) 159,873 -12%     
   Avelar Rui See Remarks   •       –      –    2024-02-21 4 A $0.00 $0 D/D 13,115 401,712     -
   Moatazedi David See Remarks   •       •      –    2024-02-21 4 A $0.00 $0 D/D 61,202 800,122     -
   Beaver Sandra Chief Financial Officer   •       –      –    2024-02-21 4 A $0.00 $0 D/D 13,115 161,694     -
   Beaver Sandra Chief Financial Officer   •       –      –    2024-02-07 4 A $0.00 $0 D/D 35,211 148,579     -
   Hayman Robert Director   –       •      –    2024-02-07 4 A $0.00 $0 D/D 6,464 54,856     -
   Gill David N Director   –       •      –    2024-02-07 4 A $0.00 $0 D/D 6,464 44,325     -
   Stewart Brady Director   –       •      –    2024-02-07 4 A $0.00 $0 D/D 6,464 51,265     -
   Avelar Rui See Remarks   •       –      –    2024-02-07 4 A $0.00 $0 D/D 35,211 388,597     -
   Yamagishi-Dressler Tomoko Chief Marketing Officer   •       –      –    2024-02-07 4 A $0.00 $0 D/D 24,648 24,648     -
   Parschauer Karah Herdman Director   –       •      –    2024-02-07 4 A $0.00 $0 D/D 6,464 37,707     -
   Malik Vikram Director   –       •      –    2024-02-07 4 A $0.00 $0 D/D 6,464 282,014     -
   Moatazedi David See Remarks   •       •      –    2024-02-07 4 A $0.00 $0 D/D 134,976 738,920     -
   Blank Simone Director   –       •      –    2024-02-07 4 A $0.00 $0 D/D 6,464 69,747     -
   Parschauer Karah Herdman Director   –       •      –    2024-01-30 4 S $13.14 $156,733 D/D (11,931) 31,243 12%     
   Moatazedi David See Remarks   •       •      –    2023-12-08 4 S $9.73 $304,505 D/D (31,300) 603,944 -20%     
   Moatazedi David See Remarks   •       •      –    2023-12-06 4 S $10.09 $517,891 D/D (51,348) 635,244 -16%     
   Medytox Inc. Former 10% Owner   –       –      –    2023-10-16 4 S $7.50 $12,679,973 D/D (1,690,663) 3,381,326 -70%     
   Beaver Sandra Chief Financial Officer   •       –      –    2023-09-06 4 AS $9.70 $30,827 D/D (3,178) 113,368 7%     
  183 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us